Inactive Instrument

Other languages Claritas Pharmaceuticals Toronto S.E.

Equities

Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107	21-08-18
Claritas Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-28
Claritas Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30
Kalytera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-10-02

No results for this search